Lipid core nanocapsules-loaded tacrolimus: Development and evaluation of quality parameters
DOI:
https://doi.org/10.22456/2527-2616.125229Keywords:
Tacrolimus, HPLC-UV, nanotechnology, lipid-core nanocapsulesAbstract
This study aimed to revalidate an HPLC-based analytical methodology to determine tacrolimus within lipid-core nanocapsules and to evaluate the quality of such nanosystems. Chromatographic separation was achieved by employing a C18 column as a stationary phase and a ternary mixture of acetonitrile: water: phosphoric acid (700:299:1 v/v) as the mobile phase. The revalidated method proved to be linear in the range of 1-60 µg.mL−1 for tacrolimus (r2 >0.999). Detection and quantification limits were 45.38 ng.mL-1 and 137.51 ng.mL-1, respectively, which assures the methodology sensitivity. The method was also precise (RSD = 1.78% between samples). Besides, the methodology demonstrated accuracy and robustness. The lipid-core nanocapsules-loaded tacrolimus showed exclusively nanosized particles (±190 nm and polydispersity index of ≤v0.2), negative zeta potential (-13.67±1.16), and slightly acidic pH (5.58 ± 0.06), with a content of 98.90±2.32% and encapsulation rate of 99.23±0.32%. Tacrolimus-loaded in lipid-core nanocapsules-loaded tacrolimus showed stability for at least 30 days at room temperature and a sustained release profile compared to the drug in solution.
Downloads
References
Zhai J, Gu J, Yuan J, Chen J. Tacrolimus in the treatment of ocular diseases. BioDrugs. 2011 Apr 1;25(2):89-103. doi: 10.2165/11587010-000000000- 00000. PMID: 21443273.
Gao L, Liu J, Zhang Y, Chen X, Gao L, Zhang C, Liu Y, Kong P, Zhong J, Sun A, Du X, Su Y, Li H, Liu H, Peng X, Zhang X. Low incidence of acute graftversus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation. Leuk Res. 2017 Jun;57:27-36. doi: 10.1016/j.leukres.2017.02.006. Epub 2017 Feb 24. PMID: 28273549.
Ueyama A, Yamamoto M, Tsujii K, Furue Y, Imura C, Shichijo M, Yasui K. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod. J Dermatol. 2014 Feb;41(2):135-43. doi: 10.1111/1346-8138.12367. Epub 2014 Jan 3. PMID: 24387343.
Frank LA, Chaves PS, D'Amore CM, Contri RV, Frank AG, Beck RC, Pohlmann AR, Buffon A, Guterres SS. The use of chitosan as cationic coating or gel vehicle for polymeric nanocapsules: Increasing penetration and adhesion of imiquimod in vaginal tissue. Eur J Pharm Biopharm. 2017 May;114:202- 212. doi: 10.1016/j.ejpb.2017.01.021. Epub 2017 Feb 1. PMID: 28161547.
de Brum TL, Fiel LA, Contri RV, Guterres SS, Pohlmann AR. Polymeric Nanocapsules and LipidCore Nanocapsules Have Diverse Skin Penetration. J Nanosci Nanotechnol. 2015 Jan;15(1):773-80. doi: 10.1166/jnn.2015.9185. PMID: 26328441.
Mora-Huertas CE, Fessi H., & Elaissari A. Polymerbased nanocapsules for drug delivery. International Journal of Pharmaceutics, 2010; 385(1-2), 113–142. doi:10.1016/j.ijpharm.2009.10.018.
Guterres SS, Alves MP, Pohlmann AR. Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights. 2007;2:147-57. Epub 2007 Jul 11. PMID: 21901071; PMCID: PMC3155227.
Pivetta TP, Simões S, Araújo MM, Carvalho T, Arruda C, Marcato PD. Development of nanoparticles from natural lipids for topical delivery of thymol: Investigation of its anti-inflammatory properties. Colloids Surf B Biointerfaces. 2018 Apr 1;164:281- 290. doi: 10.1016/j.colsurfb.2018.01.053. Epub 2018 Jan 31. PMID: 29413607.
Jain A, Doppalapudi S, Domb AJ, Khan W. Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis. J Control Release. 2016;243:132-145. doi:10.1016/j.jconrel.2016.10.004
Thapa RK, Yoo BK. Evaluation of the effect of tacrolimus-loaded liquid crystalline nanoparticles on psoriasis-like skin inflammation. J Dermatolog Treat. 2014;25(1):22-25. doi:10.3109/09546634.2012.755250
Jain S, Addan R, Kushwah V, Harde H, Mahajan RR. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations. Int J Pharm. 2019;562:96- 104. doi:10.1016/j.ijpharm.2019.03.042
Nam H, Ji XY, Park JS. Investigation of tacrolimus loaded nanostructured lipid carriers for topical drug delivery. Bulletin of the Korean Chemical Society v.32, p.956–960, 2011.
Viegas JSR, Praça FG, Caron AL, et al. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis. Drug Deliv Transl Res. 2020;10(3):646-660. doi:10.1007/s13346-020-00723-6.
Lapteva M, Mondon K, Möller M, Gurny R, Kalia YN. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis. Mol Pharm. 2014;11(9):2989- 3001. doi:10.1021/mp400639e.
Sahu S, Katiyar SS, Kushwah V, Jain S. Active natural oil-based nanoemulsion containing tacrolimus for synergistic antipsoriatic efficacy. Nanomedicine (Lond). 2018;13(16):1985-1998. doi:10.2217/nnm2018-0135
Gabriel D, Mugnier T, Courthion H, et al. Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis. J Control Release. 2016;242:16-24. doi:10.1016/j.jconrel.2016.09.007
Jäger E, Venturini CG, Poletto FS, et al. Sustained release from lipid-core nanocapsules by varying the core viscosity and the particle surface area. J Biomed Nanotechnol. 2009;5(1):130-140. doi:10.1166/jbn.2009.1004.
Pohlmann AR, Fonseca FN, Paese K, et al. Poly(ϵcaprolactone) microcapsules and nanocapsules in drug delivery. Expert Opin Drug Deliv. 2013;10(5):623- 638. doi:10.1517/17425247.2013.769956
Venturini CG, Bruinsmann FA, Contri RV, et al. Coencapsulation of imiquimod and copaiba oil in novel nanostructured systems: promising formulations against skin carcinoma. Eur J Pharm Sci. 2015;79:36- 43. doi:10.1016/j.ejps.2015.08.016
Fiel LA, Rebêlo L M., de Melo Santiago T, Adorne MD, Guterres SS, Soares de Sousa J, & Pohlmann A R.. Diverse deformation properties of polymeric nanocapsules and lipid-core nanocapsules. Soft Matter, 2011; 7(16), 7240. doi:10.1039/c1sm05508a.
Calgaroto S, Fauri LE, Frank LA, Paese K, Guterres SS, Pohlmann AR. Data of characterization and related assays of lipid-core nanocapsule formulations and their hydrolysis mechanism. Data Brief. 2018;21:918-933. Published 2018 Oct 12. doi:10.1016/j.dib.2018.10.027
Friedrich RB, Dimer FA, Guterres SS, Beck RC, Pohlmann AR. Nanoencapsulation of tacrolimus in lipid-core nanocapsules showed similar immunosuppressive activity after oral and intraperitoneal administrations. J Biomed Nanotechnol. 2014;10(8):1599-1609. doi:10.1166/jbn.2014.1842.
Friedrich RB, Coradini K, Fonseca FN, Guterres SS, Beck RC, Pohlmann AR. Lipid-Core Nanocapsules Improved Antiedematogenic Activity of Tacrolimus in Adjuvant-Induced Arthritis Model. J Nanosci Nanotechnol. 2016;16(2):1265-1274. doi:10.1166/jnn.2016.11673.
Schaffazick SR, Guterres SS, Freitas L de L, & Pohlmann AR. Caracterização e estabilidade físicoquímica de sistemas poliméricos nanoparticulados para administração de fármacos. Química Nova, 2003; 26(5), 726–737. doi:10.1590/s0100- 40422003000500017.
Brazil. Resolução RDC no 166 de 24 de julho de 2017- Critérios para a validação de métodos analíticos. Órgão emissor: ANVISA – Agência Nacional de Vigilância Sanitária.
International Conference On Harmonisation. Validation of analytical procedures: Text and methodology.Q2(R1). London: ICH, 2005 (ICH Harmonised Tripartite Guideline)
Bianchin MD, Külkamp-Guerreiro IC, De Oliveira CP, Contri RV, Guterres SS, Pohlmann A R. Radar charts based on particle sizing as an approach to establish the fingerprints of polymeric nanoparticles in aqueous formulations. Journal of Drug Delivery Science and Technology, v.30, p.180–189, 2015.
Filipe V, Hawe A, Jiskoot W. Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res. 2010;27(5):796-810. doi:10.1007/s11095-010-0073-2.
Colomé LM, Freitas GM, Bastiani JM, Pereira TCB, Bajerski L, Bender EA, Haas SE. Validation of analytical method by HPLC for determination of dapsone in polymeric nanocapsules based on crude rice brain oil. Journal Of Applied Pharmaceutical Science v.7, p.230–233, 2017.
Gomes GS, Maciel TR, Piegas EM, et al. Optimization of Curcuma Oil/Quinine-Loaded Nanocapsules for Malaria Treatment. AAPS PharmSciTech. 2018;19(2):551-564. doi:10.1208/s12249-017-0854-6.
Paese K, Jäger A, Poletto FS, et al. Semisolid formulation containing a nanoencapsulated sunscreen: effectiveness, in vitro photostability and immune response. J Biomed Nanotechnol. 2009;5(3):240-246. doi:10.1166/jbn.2009.1028.
Dos Santos PP, Paese K, Guterres SS, Pohlmann AR, Costa TH, Jablonski A, Rios A Development of lycopene-loaded lipid-core nanocapsules: physicochemical characterization and stability study. Journal of Nanoparticle Research, v.17(2), p.2917-5, 2015.
Oliveira CP, Venturini CG, Donida B, Poletto FS, Guterres SS, Pohlmann A R. An algorithm to determine the mechanism of drug distribution in lipidcore nanocapsule formulations. Soft Matter, v. 9, n. 4, p. 1141-1150, 2013.
Savian AL, Rodrigues D, Weber J, et al. Dithranolloaded lipid-core nanocapsules improve the photostability and reduce the in vitro irritation potential of this drug. Mater Sci Eng C Mater Biol Appl. 2015;46:69-76. doi: 10.1016/j.msec.2014.10.011.
Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev. 2011;63(6):456-469. doi:10.1016/j.addr.2011.02.001.
Da Silva, M. M; Nora, L.; Flores Cantillano, R. F.; Paese, K.; Guterres, S. S.; Pohlmann AR., Costa TMH., Rios A De O. The Production, Characterization, and the Stability of Carotenoids Loaded in Lipid-Core Nanocapsules. Food and Bioprocess Technology. v.9, p.1148–1158, 2016.
Kishore RSK, Kiese S, Fischer S, Pappenberger A, Grauschopf U, Mahler H. The Degradation of Polysorbates 20 and 80 and its Potential Impact on the Stability of Biotherapeutics. Pharmaceutical Research v.28, p.1194–1210, 2011.
Can E, Udenir G, Kanneci AI, Kose G, Bucak S. Investigation of PLLA/PCL blends and paclitaxel release profiles. AAPS PharmSciTech. 2011;12(4):1442-1453. doi:10.1208/s12249-011- 9714-y.
Larson NR, Wei Y, Prajapati I, et al. Comparison of Polysorbate 80 Hydrolysis and Oxidation on the Aggregation of a Monoclonal Antibody. J Pharm Sci. 2020;109(1):633-639. doi:10.1016/j.xphs.2019.10.069.
Casarini TPA, Frank LA, Benin T, Onzi G, Pohlmann AR, Guterres SS. Innovative hydrogel containing polymeric nanocapsules loaded with phloretin: Enhanced skin penetration and adhesion. Mater Sci Eng C Mater Biol Appl. 2021;120:111681. doi:10.1016/j.msec.2020.111681.
Abouelmagd SA, Sun B, Chang AC, Ku YJ, Yeo Y. Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right?. Mol Pharm. 2015;12(3):997-1003. doi:10.1021/mp500817h.
Downloads
Published
Versions
- 25-03-2026 (2)
- 28-07-2022 (1)
How to Cite
Issue
Section
License
Copyright (c) 2022 Drug Analytical Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Copyright holder of manuscripts published is Drug Analytical Research. Authors who publish with this journal are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Licensing:
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.
